Study reveals that autoantibodies in 20-30% of long COVID patients may drive debilitating symptoms like pain and fatigue, highlighting the disease's complexity. PMID:42208496, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00511-8 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00511-8
No description available
cell.com